HomeComparePAFRF vs JNJ

PAFRF vs JNJ: Dividend Comparison 2026

PAFRF yields 1.61% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PAFRF wins by $25.93M in total portfolio value
10 years
PAFRF
PAFRF
● Live price
1.61%
Share price
$1.80
Annual div
$0.03
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.95M
Annual income
$23,184,499.61
Full PAFRF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PAFRF vs JNJ

📍 PAFRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPAFRFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PAFRF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PAFRF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PAFRF
Annual income on $10K today (after 15% tax)
$136.71/yr
After 10yr DRIP, annual income (after tax)
$19,706,824.67/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, PAFRF beats the other by $19,706,121.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PAFRF + JNJ for your $10,000?

PAFRF: 50%JNJ: 50%
100% JNJ50/50100% PAFRF
Portfolio after 10yr
$12.99M
Annual income
$11,592,663.70/yr
Blended yield
89.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PAFRF
No analyst data
Altman Z
8.3
Piotroski
8/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PAFRF buys
0
JNJ buys
0
No recent congressional trades found for PAFRF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPAFRFJNJ
Forward yield1.61%3.36%
Annual dividend / share$0.03$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR100%5.8%
Portfolio after 10y$25.95M$20.0K
Annual income after 10y$23,184,499.61$827.78
Total dividends collected$25.71M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PAFRF vs JNJ ($10,000, DRIP)

YearPAFRF PortfolioPAFRF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,022$321.68$10,676$355.77+$346.00PAFRF
2$12,456$662.70$11,407$389.39+$1.0KPAFRF
3$14,728$1,399.88$12,198$426.53+$2.5KPAFRF
4$18,852$3,093.83$13,056$467.62+$5.8KPAFRF
5$27,575$7,402.47$13,987$513.12+$13.6KPAFRF
6$49,743$20,237.82$14,998$563.56+$34.7KPAFRF
7$121,463$68,238.53$16,098$619.52+$105.4KPAFRF
8$441,418$311,452.36$17,295$681.69+$424.1KPAFRF
9$2,587,964$2,115,647.06$18,599$750.82+$2.57MPAFRF
10$25,953,621$23,184,499.61$20,022$827.78+$25.93MPAFRF

PAFRF vs JNJ: Complete Analysis 2026

PAFRFStock

Pan African Resources PLC engages in the mining, extraction, production, and the sale of gold in South Africa. The company's flagship projects include the Barberton gold project that consists of three underground mines, including Fairview, Sheba, and Consort located in the Barberton Greenstone Belt; and Elikhulu tailings retreatment plant in Southern Africa. Pan African Resources PLC was incorporated in 2000 and is based in Johannesburg, South Africa.

Full PAFRF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PAFRF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PAFRF vs SCHDPAFRF vs JEPIPAFRF vs OPAFRF vs KOPAFRF vs MAINPAFRF vs ABBVPAFRF vs MRKPAFRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.